| pubmed-article:8164266 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8164266 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:8164266 | lifeskim:mentions | umls-concept:C0034786 | lld:lifeskim |
| pubmed-article:8164266 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:8164266 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:8164266 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:8164266 | lifeskim:mentions | umls-concept:C0599278 | lld:lifeskim |
| pubmed-article:8164266 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:8164266 | pubmed:dateCreated | 1994-5-24 | lld:pubmed |
| pubmed-article:8164266 | pubmed:abstractText | 7 alpha-Iodo-17 beta-hydroxy-5 alpha-androstan-3-one (7 alpha-iodo-5 alpha-dihydrotestosterone, 7 alpha-IDHT) has been synthesized as a potential radioligand for the detection and measurement of androgen receptor and for imaging of androgen-receptor-containing tissues when labeled with the gamma-emitting radionuclides 125I and 123I, respectively. In vitro binding studies show that 7 alpha-IDHT binds with high affinity to the rat and human androgen receptor (RBA = 74) compared to R1881 (RBA = 100). Further, this compound showed high specificity for the androgen receptor. 7 alpha-IDHT showed only a marginal affinity for the progestin receptor and even less affinity for the estrogen receptor. No binding was detected to the glucocorticoid receptor. These characteristics make 7 alpha-IDHT a potentially ideal agent for imaging and evaluation of androgen-receptor-containing tissues. | lld:pubmed |
| pubmed-article:8164266 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8164266 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8164266 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8164266 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8164266 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:8164266 | pubmed:author | pubmed-author:HochbergR BRB | lld:pubmed |
| pubmed-article:8164266 | pubmed:author | pubmed-author:AllenRR | lld:pubmed |
| pubmed-article:8164266 | pubmed:author | pubmed-author:BrownT JTJ | lld:pubmed |
| pubmed-article:8164266 | pubmed:author | pubmed-author:BrysonKK | lld:pubmed |
| pubmed-article:8164266 | pubmed:author | pubmed-author:HoyteR MRM | lld:pubmed |
| pubmed-article:8164266 | pubmed:author | pubmed-author:BorderonKK | lld:pubmed |
| pubmed-article:8164266 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8164266 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8164266 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:8164266 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8164266 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8164266 | pubmed:pagination | 1224-30 | lld:pubmed |
| pubmed-article:8164266 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:meshHeading | pubmed-meshheading:8164266-... | lld:pubmed |
| pubmed-article:8164266 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8164266 | pubmed:articleTitle | Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor. | lld:pubmed |
| pubmed-article:8164266 | pubmed:affiliation | Department of Chemistry, State University of New York, Old Westbury 11568. | lld:pubmed |
| pubmed-article:8164266 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8164266 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8164266 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8164266 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:8164266 | lld:chembl |
